Stocks
Edwards Lifesciences (EW) EBITDA margin US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 24.5% | 36.1% | 33.1% | 36.4% | 29.4% | 27.7% | ||
| Changes by years, y/y, % | -6pp | +12pp | -3pp | +3pp | -7pp | -4.6% | |||
Edwards Lifesciences. EBITDA margin, %
Edwards Lifesciences. EBITDA margin, changes, pp
Edwards Lifesciences (EW) EBITDA margin US GAAP (quarter values) |
||||||||
| 2024Q1 | 2024Q1 | 2024Q2 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA margin, % | ? | 24.2% | 24.9% | 26.6% | 30.1% | 29.7% | 27.7% | |
| Changes by years, y/y, % | -8pp | -8pp | -11pp | -7pp | -1pp | |||
| Changes by quarters, q/q, % | -6pp | +1pp | +2pp | +3pp | 0pp | |||
